til randomiseret til behandling med fondaparinux 2, 5 mg en gang daglig eller placebo i yderligere 21 ± 2 dage.
At the end of this period, 656 patients were randomised to receive fondaparinux 2.5 mg once daily or placebo for an additional 21 +/ - 2 days.